Turn H&E tissue tiles into clear pathology signals.
OsteoPath AI demonstrates a three-class deep-learning workflow that distinguishes non-tumor tissue, non-viable tumor and viable osteosarcoma from histopathology images.
A classification system, not a segmentation system.
The model receives a complete histology tile and assigns it to one predominant tissue category. It does not draw tumor boundaries pixel by pixel; instead, it learns visual patterns across the tile and produces class probabilities.
Read the tissue tile
A 10× H&E image tile contains color, cellular density, matrix structure, necrotic change and surrounding non-tumor anatomy.
Learn discriminative texture
EfficientNetV2 extracts progressively richer features—from stain edges and nuclei to larger tissue architecture.
Estimate three probabilities
The final classifier compares evidence for non-tumor, non-viable tumor and viable tumor, then ranks the likely class.
Support review
The predicted category can help organize large tile collections for expert review, quality control and research analysis.
See how the three tissue groups differ.
The viewer rotates through the project’s original dataset contact sheets. Every image is displayed with contain-fit framing so the entire scientific source remains visible.
Densely cellular malignant tissue with active tumor morphology and stronger hematoxylin-rich nuclear detail.
Viable tumor
Predominantly active tumor tissue. These tiles often show dense cellularity and viable malignant morphology.
30% of the complete datasetNon-viable tumor
Predominantly necrotic or treatment-affected tumor tissue with loss of viable cellular architecture.
23% of the complete datasetNon-tumor
Bone, marrow, fat and other tissue without predominant osteosarcoma morphology.
47% of the complete datasetFrom pathology tile to ranked tissue class.
The implementation fine-tunes an EfficientNetV2-M model rather than training every visual feature from zero.
H&E tile
Annotated 1024 × 1024 pathology image
Augmentation
Rotation, flips, shifts, shear and zoom
EfficientNetV2-M
Transfer learning with 40% trainable layers
Softmax scores
Three normalized class probabilities
Review output
Prediction, score and evaluation report
- Backbone
- EfficientNetV2-M
- Training input
- 384 px
- Evaluation input
- 480 px
- Optimizer
- RMSprop
- Learning rate
- 0.0001
- Dropout
- 0.4
- Batch size
- 4
- Maximum epochs
- 50
Augmentation changes orientation and scale while preserving the tissue class, encouraging the network to learn morphology rather than memorizing one layout.
Evaluation on 220 held-out images.
These figures reproduce the experimental report supplied with the project. They are not a prospective clinical validation.
200 correct predictions out of 220 test images
Average sensitivity across the three classes
Class-frequency weighted harmonic score
108 non-tumor · 53 non-viable · 59 viable
Where predictions agreed—and where they did not.
Precision, recall and F1
Inspect the project’s training and evaluation evidence.
Full source image shown · no cropping
A practical demonstration for digital pathology workflows.
For instrument and laboratory presentations, the project shows how AI can sit downstream of slide scanning: ingesting exported image tiles, prioritizing tissue categories and presenting transparent confidence scores for human review.
Faster triageOrganize large image collections before detailed expert review.
Consistent categorizationApply the same learned decision function to every processed tile.
Instrument-ready storyConnect scanner output, AI analysis, review and reporting in one visual workflow.
Research extensibilityAdd attention maps, whole-slide aggregation, quality checks and case-level analytics.
tile ingestion ✓
stain normalization ✓
feature extraction ✓
class ranking ✓
review package ✓
From stained tissue to structured insight.
A polished research presentation for AI-enabled pathology and laboratory instrumentation.
This website presents an experimental image-classification workflow and reported retrospective results. It is not a medical device, does not replace pathologist review and must not be used for diagnosis or treatment decisions without appropriate validation, governance and regulatory approval.